Allianz


Good 2020 figures in COVID-19 times

19/02/21 -"• Net profit attributable to shareholders decreased by 14% to €6.8bn for 2020 • Despite an equity increase of 9% and COVID-19 burdens the RoE was 11.4% for FY2020 • COVID-19 contributed “only” a ..."

Pages
48
Language
English
Published on
19/02/21
You may also be interested by these reports :
13/11/26
Five years on, European insurers have plainly struck gold. Whether the sharp 2022 rate rises aimed at taming post-Covid inflation lit the fuse is ...

13/11/26
Generali has released 3Q26 results slightly below expectations, though we believe this is partly due to higher-than-expected natural catastrophe and ...

12/11/26
Talanx reported a strong set of 3Q26 results and upgraded its FY26 guidance. Despite the softening Property & Casualty (P&C) reinsurance market, its ...

11/11/26
Swiss Life’s 3Q figures were mixed, in our view. While recurring fee income growth at Asset Managers was strong in Q3, group-level fee and commission ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO